z-logo
open-access-imgOpen Access
Efficacy of a Novel Medical Adhesive for Sealing Lung Parenchyma: An in vitro Study in Rabbit Lungs
Author(s) -
Sebastian Kalverkamp,
Anna Mantas,
Jan Spillner,
Flutura Hima,
Stephanie Kanzler,
Thaddäus Stopinski,
René Tolba,
Rashad Zayat
Publication year - 2021
Publication title -
european surgical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.658
H-Index - 46
eISSN - 1421-9921
pISSN - 0014-312X
DOI - 10.1159/000517173
Subject(s) - in vivo , fibrous joint , medicine , surgery , leak , lung , parenchyma , anesthesia , pathology , biology , microbiology and biotechnology , environmental engineering , engineering
During thoracic resection procedures, complete hemostasis and aerostasis are priorities. A persistent alveolar air leak is associated with increased morbidity and mortality rates. This study aimed to evaluate whether the novel medical adhesive VIVO (Adhesys Medical GmbH Aachen, Germany) is a reliable alternative sealing technique to routine surgical procedures. Methods: We conducted an in vitro animal study by analyzing 21 lungs of New Zealand ( n = 19) and Chinchilla Bastard ( n = 2) rabbits (age, 11–18 weeks; weight, 2,400–3,600 g). Three groups, each comprising 7 animals, were evaluated. VIVO (VIVO-group) was compared with standard surgical lung parenchymal lesion closure with a polypropylene suture (Suture-group) and TachoSil® (TachoSil-group). We adopted a stable, pressure-controlled ventilation protocol. After explantation, a surgical incision 0.5-cm deep and 1.5-cm wide was made in the lungs using a customized template. Air leak was measured quantitatively (mL/min) using a respirator and visualized qualitatively by 2 observers who made independent judgments. Next, the leak was closed using VIVO, suture, or TachoSil® as specified by the manufacturer. Subsequently, positive end-expiratory pressure (PEEP) and inspiratory pressure were gradually increased until a maximum of 15 and 30 mbar were attained, respectively. Results: At PEEPs of 8, 10, and 15 mbar, VIVO achieved complete sealing of the profound parenchymal defect in all ( n = 7) lungs. After closure of the incision, we observed an air leak variation of 127 ± 114 mL/min (Suture-group), 31 ± 49 mL/min (VIVO-group), and 114 ± 134 mL/min (TachoSil-group). VIVO showed a significantly lower air leak than surgical sutures ( p = 0.031) and TachoSil® ( p = 0.046). Conclusion: VIVO offers sufficient closure of the lung parenchymal lesions. The novel adhesive enabled significantly better sealing with lower persistent air leakage than TachoSil® or surgical sutures. Further investigation using in vivo models is strongly encouraged to confirm our findings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here